BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Booth CL, Thompson KS. Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments. J Gastrointest Oncol 2012;3:232-42. [PMID: 22943014 DOI: 10.3978/j.issn.2078-6891.2012.028] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
Number Citing Articles
1 Wang J. Pathologic aspects of tumors of gastrointestinal tract in the era of personalized medicine. J Gastrointest Oncol 2012;3:151-2. [PMID: 22943007 DOI: 10.3978/j.issn.2078-6891.2012.039] [Reference Citation Analysis]
2 Attendu X, Bourget MH, de Sivry-Houle MP, Boudoux C. Coregistered optical coherence tomography and frequency-encoded multispectral imaging for spectrally sparse color imaging. J Biomed Opt 2019;25:1-12. [PMID: 31755250 DOI: 10.1117/1.JBO.25.3.032008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Mittal SK, Abdo J, Adrien MP, Bayu BA, Kline JR, Sullivan MM, Agrawal DK. Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature review. J Gastrointest Oncol 2021;12:1197-214. [PMID: 34532080 DOI: 10.21037/jgo-21-117] [Reference Citation Analysis]
4 Huhta H, Helminen O, Lehenkari PP, Saarnio J, Karttunen TJ, Kauppila JH. Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma. Oncotarget 2016;7:23658-67. [PMID: 27008696 DOI: 10.18632/oncotarget.8151] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
5 Dhaliwal A, Saghir SM, Mashiana HS, Braseth A, Dhindsa BS, Ramai D, Taunk P, Gomez-Esquivel R, Dam A, Klapman J, Adler DG. Endoscopic cryotherapy: Indications, techniques, and outcomes involving the gastrointestinal tract. World J Gastrointest Endosc 2022; 14(1): 17-28 [DOI: 10.4253/wjge.v14.i1.17] [Reference Citation Analysis]
6 Illig R, Klieser E, Kiesslich T, Neureiter D. GERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers? Gastroenterol Res Pract. 2013;2013:643084. [PMID: 23573078 DOI: 10.1155/2013/643084] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
7 Storz L, Walther P, Chemnitzer O, Lyros O, Niebisch S, Mehdorn M, Jansen-Winkeln B, Moulla Y, Büch T, Gockel I, Thieme R. Nrf2/Keap1-Pathway Activation and Reduced Susceptibility to Chemotherapy Treatment by Acidification in Esophageal Adenocarcinoma Cells. Cancers (Basel) 2021;13:2806. [PMID: 34199909 DOI: 10.3390/cancers13112806] [Reference Citation Analysis]
8 Guleria S, Shah TU, Pulido JV, Fasullo M, Ehsan L, Lippman R, Sali R, Mutha P, Cheng L, Brown DE, Syed S. Deep learning systems detect dysplasia with human-like accuracy using histopathology and probe-based confocal laser endomicroscopy. Sci Rep 2021;11:5086. [PMID: 33658592 DOI: 10.1038/s41598-021-84510-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Maitra I, Date RS, Martin FL. Towards screening Barrett's oesophagus: current guidelines, imaging modalities and future developments.Clin J Gastroenterol. 2020;13:635-649. [PMID: 32495144 DOI: 10.1007/s12328-020-01135-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]